0001209191-19-056639.txt : 20191114
0001209191-19-056639.hdr.sgml : 20191114
20191114214400
ACCESSION NUMBER: 0001209191-19-056639
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191108
FILED AS OF DATE: 20191114
DATE AS OF CHANGE: 20191114
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leber Laura
CENTRAL INDEX KEY: 0001649191
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51541
FILM NUMBER: 191222292
MAIL ADDRESS:
STREET 1: C/O GENOMIC HEALTH, INC.
STREET 2: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOMIC HEALTH INC
CENTRAL INDEX KEY: 0001131324
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 770552594
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-556-9300
MAIL ADDRESS:
STREET 1: 301 PENOBSCOT DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-11-08
1
0001131324
GENOMIC HEALTH INC
GHDX
0001649191
Leber Laura
301 PENOBSCOT DR.
REDWOOD CITY
CA
94063
0
1
0
0
Chief Communication Officer
Common Stock
2019-11-08
4
D
0
4352
0.00
D
9384
D
Common Stock
2019-11-08
4
D
0
9384
0.00
D
0
D
Employee Stock Option (right to buy)
29.34
2019-11-08
4
D
0
15000
0.00
D
2022-02-03
Common Stock
15000
0
D
Employee Stock Option (right to buy)
28.05
2019-11-08
4
D
0
11250
0.00
D
2023-01-31
Common Stock
11250
0
D
Employee Stock Option (right to buy)
30.84
2019-11-08
4
D
0
10220
0.00
D
2024-01-28
Common Stock
10220
0
D
Employee Stock Option (right to buy) Holding
31.12
2019-11-08
4
D
0
9000
0.00
D
2025-02-13
Common Stock
9000
0
D
Employee Stock Option (right to buy) Holding
27.00
2019-11-08
4
D
0
11458
0.00
D
2026-02-16
Common Stock
11458
1042
D
Employee Stock Option (right to buy) Holding
27.00
2019-11-08
4
D
0
1042
0.00
D
2026-02-16
Common Stock
1042
0
D
Employee Stock Option (right to buy) Holding
27.48
2019-11-08
4
D
0
8366
0.00
D
2027-01-31
Common Stock
8366
3804
D
Employee Stock Option (right to buy) Holding
27.48
2019-11-08
4
D
0
3804
0.00
D
2027-01-31
Common Stock
3804
0
D
Employee Stock Option (right to buy) Holding
33.21
2019-11-08
4
D
0
6190
0.00
D
2028-01-31
Common Stock
6190
7960
D
Employee Stock Option (right to buy) Holding
33.21
2019-11-08
4
D
0
7960
0.00
D
2028-01-31
Common Stock
7960
0
D
Employee Stock Option (right to buy) Holding
72.52
2019-11-08
4
D
0
8100
0.00
D
2029-01-29
Common Stock
8100
0
D
Disposed of in connection with the acquisition of Issuer (the "Merger") by Exact Sciences Corporation ("Exact Sciences") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the "Merger Agreement"), among Exact Sciences,Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $119,704 and 1,960 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer restricted stock unit ("RSU") was assumed by Exact Sciences and converted into a corresponding award for 7,180 RSUs of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $231,418, less applicable tax withholdings, and 3,790 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $179,535, less applicable tax withholdings, and 2,940 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $151,366, less applicable tax withholdings, and 2,479 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $132,260, less applicable tax withholdings, and 2,166 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $187,805, less applicable tax withholdings, and 3,076 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 797 shares of Exact Sciences common stock with an exercise price of $35.28 per share.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $135,473, less applicable tax withholdings, and 2,218 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 2,911 shares of Exact Sciences common stock with an exercise price of $35.91 per share.
Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $85,642, less applicable tax withholdings, and 1,402 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 6,092 shares of Exact Sciences common stock with an exercise price of $43.40 per share.
Disposed of in connection with the Merger, whereby such Issuer stock option was assumed by Exact Sciences and converted into a corresponding award for an option to purchase 6,199 shares of Exact Sciences common stock with an exercise price of $94.76 per share.
/s/ G. Bradley Cole, Attorney-in-fact
2019-11-14